Screen Shot 2018-08-30 at 16.40.44.png

The Evox Ecosystem

A core component of Evox’s strategy is to support and drive scientific exploration within the exosome space, with a relentless focus on translating scientific discoveries into patient benefits. To this end, Evox has established an extensive network of scientific advisors and collaborators globally. 

Evox scientific advisory board:

Professor Matthew Wood, University of Oxford

Assistant Professor Samir EL Andaloussi, Karolinska Institutet

Dr Bernd Giebel, University Hospital Essen

Professor Xandra Breakefield, Harvard Medical School and Massachusetts General Hospital

Professor Anastasia Khvorova, RNAi Therapeutics Institute, University of Massachusetts

Professor Robert Langer, Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology